{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:49:35Z","timestamp":1757778575015},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_cclm-2016-0063_s_999_w2aab2b8c81b1b7b1aab1c14b1Aa\">\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p> Measurement of holotranscobalamin (holoTC) is increasingly used as a screening test for cobalamin (Cbl) deficiency. A level well below the reference interval strongly supports a deficient state. We examined a 21-year-old woman diagnosed as Cbl deficient because of an extremely low holoTC level as measured by the Abbott Architect Assay.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2016-0063_s_998_w2aab2b8c81b1b7b1aab1c14b2Aa\">\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p> The patient was evaluated for Cbl deficiency employing an in-house holoTC method as well as other routine markers of Cbl status. Further analyses included exploration of the Cbl binding proteins employing gel filtration of a serum sample saturated with 57 Co-labeled Cbl and Sanger sequencing of exons 1\u20139 and the intron-exon boundaries of the <jats:italic>TCN2<\/jats:italic> gene, the gene coding for transcobalamin (TC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2016-0063_s_997_w2aab2b8c81b1b7b1aab1c14b3Aa\">\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p> The patient had normal hematological variables throughout. Despite initial treatment with Cbl, holoTC as measured by the Abbott assay remained low, while holoTC measured with the in-house assay was normal, and behaved as TC upon gel-filtration. By Sanger sequencing, we detected a homozygous single point mutation c.855T&gt;A in exon 6 of <jats:italic>TCN2<\/jats:italic>, corresponding to a asparagine (Asn) to lysine (Lys) substitution in position 267 of the mature protein.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2016-0063_s_996_w2aab2b8c81b1b7b1aab1c14b4Aa\">\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p> We describe a novel point mutation of the <jats:italic>TCN2<\/jats:italic> gene. The mutation does not seem to interfere with the function of TC, but the mutation may well explain the low level of holoTC detected by the Abbott assay. Our results underscores that mutations of <jats:italic>TCN2<\/jats:italic> have to be considered when implausible holoTC results are obtained.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/cclm-2016-0063","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T10:01:36Z","timestamp":1462528896000},"page":"1739-1743","source":"Crossref","is-referenced-by-count":10,"title":["False low holotranscobalamin levels in a patient with a novel <i>TCN2<\/i> mutation"],"prefix":"10.1515","volume":"54","author":[{"given":"Peter","family":"Keller","sequence":"first","affiliation":[{"name":"Central Hematology Laboratory, University Clinic of Hematology, Bern University Hospital, Inselspital, Freiburgstr, Bern 3010, Switzerland , Phone: +41316321390, Fax: +41316323406"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Rufener","sequence":"additional","affiliation":[{"name":"Central Hematology Laboratory, University Clinic of Hematology, Bern University Hospital, Inselspital, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Schild","sequence":"additional","affiliation":[{"name":"University Institute of Clinical Chemistry, Bern University Hospital, Inselspital, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey N.","family":"Fedosov","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Molecular Nutrition, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"Nissen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebba","family":"Nexo","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"2023033110175286749_j_cclm-2016-0063_ref_001_w2aab2b8c81b1b7b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Heil SG, de Jonge R, de Rotte MC, van Wijnen M, Heiner-Fokkema RM, Kobold AC, et al. Screening for metabolic vitamin B12 deficiency by holotranscobalamin in patients suspected of vitamin B12 deficiency: a multicentre study. Ann Clin Biochem 2012;49:184\u20139.","DOI":"10.1258\/acb.2011.011039"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_002_w2aab2b8c81b1b7b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Miller JW, Garrod MG, Rockwood AL, Kushnir MM, Allen LH, Haan MN, et al. Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin Chem 2006;52:278\u201385.","DOI":"10.1373\/clinchem.2005.061382"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_003_w2aab2b8c81b1b7b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Ulleland M, Eilertsen I, Quadros EV, Rothenberg SP, Fedosov SN, Sundrehagen E, et al. Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum. Clin Chem 2002;48:526\u201332.","DOI":"10.1093\/clinchem\/48.3.526"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_004_w2aab2b8c81b1b7b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Nexo E, Hvas AM, Bleie O, Refsum H, Fedosov SN, Vollset SE, et al. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem 2002;48:1768\u201371.","DOI":"10.1093\/clinchem\/48.10.1768"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_005_w2aab2b8c81b1b7b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Refsum H, Johnston C, Guttormsen AB, Nexo E. Holotranscobalamin and total transcobalamin in human plasma: determination, determinants, and reference values in healthy adults. Clin Chem 2006;52:129\u201337.","DOI":"10.1373\/clinchem.2005.054619"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_006_w2aab2b8c81b1b7b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Obeid R, Herrmann W. Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid. Clin Chem Lab Med 2007;45:1746\u201350.","DOI":"10.1515\/CCLM.2007.361"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_007_w2aab2b8c81b1b7b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Valente E, Scott JM, Ueland PM, Cunningham C, Casey M, Molloy AM. Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B(1)(2) status in the elderly. Clin Chem 2011;57:856\u201363.","DOI":"10.1373\/clinchem.2010.158154"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_008_w2aab2b8c81b1b7b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Nexo E, Hoffmann-Lucke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 2011;94:359S\u201365S.","DOI":"10.3945\/ajcn.111.013458"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_009_w2aab2b8c81b1b7b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Nielsen MJ, Rasmussen MR, Andersen CB, Nexo E, Moestrup SK. Vitamin B12 transport from food to the body\u2019s cells \u2013 a sophisticated, multistep pathway. Nat Rev Gastroenterol Hepatol 2012;9:345\u201354.","DOI":"10.1038\/nrgastro.2012.76"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_010_w2aab2b8c81b1b7b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Quadros EV, Sequeira JM. Cellular uptake of cobalamin: transcobalamin and the TCblR\/CD320 receptor. Biochimie 2013;95:1008\u201318.","DOI":"10.1016\/j.biochi.2013.02.004"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_011_w2aab2b8c81b1b7b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Ratschmann R, Minkov M, Kis A, Hung C, Rupar T, Muhl A, et al. Transcobalamin II deficiency at birth. Mol Genet Metab 2009;98:285\u20138.","DOI":"10.1016\/j.ymgme.2009.06.003"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_012_w2aab2b8c81b1b7b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Nissen PH, Nordwall M, Hoffmann-Lucke E, Sorensen BS, Nexo E. Transcobalamin deficiency caused by compound heterozygosity for two novel mutations in the TCN2 gene: a study of two affected siblings, their brother, and their parents. J Inherit Metab Dis 2010;33(Suppl 3):S269\u201374.","DOI":"10.1007\/s10545-010-9145-z"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_013_w2aab2b8c81b1b7b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Trakadis YJ, Alfares A, Bodamer OA, Buyukavci M, Christodoulou J, Connor P, et al. Update on transcobalamin deficiency: clinical presentation, treatment and outcome. J Inherit Metab Dis 2014;37:461\u201373.","DOI":"10.1007\/s10545-013-9664-5"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_014_w2aab2b8c81b1b7b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Brady J, Wilson L, McGregor L, Valente E, Orning L. Active B12: a rapid, automated assay for holotranscobalamin on the Abbott AxSYM analyzer. Clin Chem 2008;54:567\u201373.","DOI":"10.1373\/clinchem.2007.096784"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_015_w2aab2b8c81b1b7b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Orning L, Rian A, Campbell A, Brady J, Fedosov SN, Bramlage B, et al. Characterization of a monoclonal antibody with specificity for holo-transcobalamin. Nutr Metab 2006;3:3.","DOI":"10.1186\/1743-7075-3-3"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_016_w2aab2b8c81b1b7b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Nexo E, Christensen AL, Petersen TE, Fedosov SN. Measurement of transcobalamin by ELISA. Clin Chem 2000;46:1643\u20139.","DOI":"10.1093\/clinchem\/46.10.1643"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_017_w2aab2b8c81b1b7b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002;48:561\u20132.","DOI":"10.1093\/clinchem\/48.3.561"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_018_w2aab2b8c81b1b7b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Morkbak AL, Pedersen JF, Nexo E. Glycosylation independent measurement of the cobalamin binding protein haptocorrin. Clin Chim Acta 2005;356:184\u201390.","DOI":"10.1016\/j.cccn.2005.01.013"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_019_w2aab2b8c81b1b7b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Hoffmann-Lucke E, Arendt JF, Nissen PH, Mikkelsen G, Aasly JO, Nexo E. Three family members with elevated plasma cobalamin, transcobalamin and soluble transcobalamin receptor (sCD320). Clin Chem Lab Med 2013;51:677\u201382.","DOI":"10.1515\/cclm-2012-0554"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_020_w2aab2b8c81b1b7b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Wuerges J, Garau G, Geremia S, Fedosov SN, Petersen TE, Randaccio L. Structural basis for mammalian vitamin B12 transport by transcobalamin. Proc Natl Acad Sci USA 2006;103:4386\u201391.","DOI":"10.1073\/pnas.0509099103"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_021_w2aab2b8c81b1b7b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Devalia V, Hamilton MS, Molloy AM, British Committee for Standards in H. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol 2014;166:496\u2013513.","DOI":"10.1111\/bjh.12959"},{"key":"2023033110175286749_j_cclm-2016-0063_ref_022_w2aab2b8c81b1b7b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Greibe E, Nexo E. Vitamin B12 absorption judged by measurement of holotranscobalamin, active vitamin B12: evaluation of a commercially available EIA kit. Clin Chem Lab Med 2011;49:1883\u20135.","DOI":"10.1515\/cclm.2011.754"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2016.54.issue-11\/cclm-2016-0063\/cclm-2016-0063.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2016-0063\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2016-0063\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T11:51:07Z","timestamp":1680263467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2016-0063\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,5,19]]},"published-print":{"date-parts":[[2016,11,1]]}},"alternative-id":["10.1515\/cclm-2016-0063"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2016-0063","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,6]]}}}